SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

This study has been terminated.

Study NCT00440271 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: February 26, 2007 Last Updated: February 11, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)